Literature DB >> 15531509

Age and secretagogue type jointly determine dynamic growth hormone responses to exogenous insulin-like growth factor-negative feedback in healthy men.

Johannes D Veldhuis1, Judith Y Weltman, Arthur L Weltman, Ali Iranmanesh, Eugenio E Muller, Cyril Y Bowers.   

Abstract

The primary cause of waning GH and IGF-I concentrations in healthy aging adults is not established. To test the postulate that age influences negative feedback by IGF-I in a secretagogue-specific fashion, 17 normal men (nine young and eight older) each completed eight randomly ordered injections of placebo or recombinant human (rh) IGF-I (20 microg/kg sc), followed by saline/rest, aerobic exercise, GHRH (1 microg/kg iv bolus), or GH-releasing peptide-2 (1 microg/kg iv bolus) stimulation. GH secretion was monitored by sampling blood every 10 min for 7 h, high-sensitivity immunochemiluminometric assay, and deconvolution analysis conditioned on prior pulse-onset times and biexponential kinetics. Analysis of covariance showed that age (P = 0.028), secretagogue (P < 0.001), and rhIGF-I (P < 0.005) individually determine pulsatile GH secretion and exhibit a strong 3-fold interaction (P < 10(-5)). Post hoc comparisons revealed that elderly subjects manifest less IGF-I inhibition of a maximal GHRH stimulus (P = 0.013 vs. young), blunted initial IGF-I suppression of fasting GH release (P = 0.038), and impaired IGF-I feedback on the regularity of GH secretion (P = 0.023). Age stratum did not influence peak IGF-I and nadir GH concentrations or rhIGF-I-induced inhibition of GH secretion stimulated by exercise or GH-releasing peptide-2. In summary, experimental elevation of IGF-I concentrations unmasks reduced rhIGF-I-dependent feedback inhibition of fasting and GHRH-stimulated GH secretion in healthy older men, indicating that aging selectively modulates the autoinhibition process.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15531509     DOI: 10.1210/jc.2004-0282

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

Review 1.  Cardiovascular risk in aging and obesity: is there a role for GH.

Authors:  M Gola; S Bonadonna; M Doga; G Mazziotti; A Giustina
Journal:  J Endocrinol Invest       Date:  2005-09       Impact factor: 4.256

2.  Effects of continuous versus intermittent exercise, obesity, and gender on growth hormone secretion.

Authors:  Arthur Weltman; Judy Y Weltman; Dee Dee Watson Winfield; Kirsten Frick; James Patrie; Petra Kok; Daniel M Keenan; Glenn A Gaesser; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2008-09-09       Impact factor: 5.958

3.  Growth Hormone Dynamics in Healthy Adults Are Related to Age and Sex and Strongly Dependent on Body Mass Index.

Authors:  Ferdinand Roelfsema; Johannes D Veldhuis
Journal:  Neuroendocrinology       Date:  2015-07-28       Impact factor: 4.914

4.  Effects of exercise training intensity on nocturnal growth hormone secretion in obese adults with the metabolic syndrome.

Authors:  Brian A Irving; J Y Weltman; James T Patrie; Christopher K Davis; David W Brock; Damon Swift; Eugene J Barrett; Glenn A Gaesser; Arthur Weltman
Journal:  J Clin Endocrinol Metab       Date:  2009-03-24       Impact factor: 5.958

5.  Estradiol supplementation in postmenopausal women attenuates suppression of pulsatile growth hormone secretion by recombinant human insulin-like growth factor type I.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Joy N Bailey; Adenborduin Adeniji; John M Miles; Remberto Paulo; Mihaela Cosma; Cacia Soares-Welch
Journal:  J Clin Endocrinol Metab       Date:  2008-08-26       Impact factor: 5.958

6.  Pilot study: an acute bout of high intensity interval exercise increases 12.5 h GH secretion.

Authors:  Sarah E Deemer; Todd J Castleberry; Chris Irvine; Daniel E Newmire; Michael Oldham; George A King; Vic Ben-Ezra; Brian A Irving; Kyle D Biggerstaff
Journal:  Physiol Rep       Date:  2018-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.